VR Adviser as of March 31, 2020
Portfolio Holdings for VR Adviser
VR Adviser holds 16 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Constellation Pharmceticls I | 34.2 | $126M | 4.0M | 31.43 | |
| Axsome Therapeutics (AXSM) | 12.9 | $48M | 810k | 58.83 | |
| Relmada Therapeutics (RLMD) | 7.8 | $29M | 843k | 34.11 | |
| Trillium Therapeutics, Inc. Cmn | 7.4 | $27M | 6.8M | 4.04 | |
| 89bio (ETNB) | 6.5 | $24M | 952k | 25.25 | |
| Inovio Pharmaceuticals | 5.8 | $22M | 2.9M | 7.44 | |
| 10x Genomics Inc Cl A (TXG) | 5.1 | $19M | 300k | 62.32 | |
| Mersana Therapeutics (MRSN) | 4.1 | $15M | 2.6M | 5.83 | |
| Marinus Pharmaceuticals | 3.6 | $13M | 6.5M | 2.03 | |
| Verastem | 2.7 | $9.8M | 3.7M | 2.64 | |
| Adverum Biotechnologies | 2.6 | $9.7M | 994k | 9.77 | |
| Iveric Bio | 2.4 | $8.9M | 2.6M | 3.44 | |
| Flamel Technologies Sa | 2.3 | $8.4M | 1.1M | 7.94 | |
| Sierra Oncology | 1.3 | $4.8M | 491k | 9.82 | |
| Spero Therapeutics (SPRO) | 1.0 | $3.8M | 474k | 8.08 | |
| Protagonist Therapeutics (PTGX) | 0.2 | $799k | 113k | 7.06 |
